Gilder Gagnon Howe & CO LLC Enzo Biochem Inc Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 30, 2018	SELL	$3.81 - $5.53 $2.91 Million - $4.22 Million	-763,219 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$5.06 - $6.78 $1.48 Million - $1.99 Million	-293,181 Reduced 27.75%	763,219 $3.96 Million
Q1 2018 Apr 30, 2018	SELL	$5.43 - $8.36 $108,122 - $166,464	-19,912 Reduced 1.85%	1,056,400 $5.79 Million
Q4 2017 Jan 31, 2018	BUY	$8.15 - $10.55 $776,735 - $1.01 Million	95,305 Added 9.72%	1,076,312 $8.77 Million
Q3 2017 Nov 06, 2017	BUY	$10.45 - $11.44 $10.3 Million - $11.2 Million	981,007	981,007 $10.3 Million

15.4M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $32.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.